TP53-inducible glycolysis and apoptosis regulator
Protein involved in cellular metabolism and apoptosis

The TP53-inducible glycolysis and apoptosis regulator (TIGAR) is a protein that plays a crucial role in cellular metabolism and the regulation of apoptosis. It is encoded by the C12orf5 gene in humans and is a target of the tumor protein p53 (TP53), a well-known tumor suppressor protein. TIGAR functions primarily by modulating the levels of fructose-2,6-bisphosphate in cells, thereby influencing the glycolytic pathway and protecting cells from oxidative stress.
Function[edit]
TIGAR acts as a fructose-2,6-bisphosphatase, which reduces the levels of fructose-2,6-bisphosphate, a potent activator of phosphofructokinase-1 (PFK-1), a key enzyme in the glycolytic pathway. By decreasing fructose-2,6-bisphosphate levels, TIGAR effectively downregulates glycolysis and shifts cellular metabolism towards the pentose phosphate pathway (PPP). This shift enhances the production of NADPH, a critical reducing agent that helps in detoxifying reactive oxygen species (ROS) and thus protects cells from oxidative damage.
Role in Apoptosis[edit]
TIGAR's ability to modulate cellular metabolism has significant implications for apoptosis, the programmed cell death process. By reducing oxidative stress, TIGAR can inhibit apoptosis, thereby promoting cell survival under conditions of stress. This function is particularly important in the context of cancer, where TIGAR expression can contribute to the survival of cancer cells by protecting them from oxidative damage and apoptosis.
Regulation[edit]
The expression of TIGAR is directly regulated by the tumor suppressor protein p53. Under conditions of cellular stress, such as DNA damage, p53 is activated and can induce the expression of TIGAR. This induction is part of the broader role of p53 in maintaining cellular homeostasis and preventing tumorigenesis by regulating various genes involved in cell cycle arrest, DNA repair, and apoptosis.
Clinical Significance[edit]
Given its role in modulating metabolism and apoptosis, TIGAR has been implicated in various diseases, particularly cancer. Overexpression of TIGAR has been observed in several types of cancer, where it may contribute to tumor progression by enhancing cell survival and resistance to chemotherapy. As such, TIGAR represents a potential target for therapeutic intervention in cancer treatment.
Related pages[edit]
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian